| Utestående aktier | 23,305,108 shares |
| Insideraktier | 3 117 423 shares |
| Insynsägande | 13,38 % |
| Totalt antal insynspersoner | 43 |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Procent av flytande köpta av insiders (ranking)
0.000 %( )
615 out of 11237Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
Rein Therapeutics Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
|
AJU IB Investment Co., Ltd.
10% Owner -
|
517 558 | 25 878 | |
|
Apple Tree Partners Ii Lp
10% Owner -
|
0 | 0 | |
| Manuel Aivado See Remarks - [O] | 1 000 | 50 | |
| Ambros Reinhard J. Director - [D] | 5 800 | 290 | |
| Allen Annis See Remarks - [O] | 15 094 | 755 | |
|
Apple Tree Partners II - Annex, L.P.
10% Owner -
|
0 | 0 | |
| Jeffrey Allen Bailey Director - [D] | 74 894 | 3 745 | |
|
Blume Frederick R.
10% Owner -
|
1 016 100 | 50 805 | |
|
Cvf, Llc
10% Owner -
|
716 180 | 35 809 | |
| Donald Dougherty SVP & Chief Financial Officer - [O] | 5 000 | 250 | |
|
Excel Medical Fund Lp
10% Owner -
|
1 016 100 | 50 805 | |
|
Juan Enriquez
10% Owner -
|
1 016 100 | 50 805 | |
|
Excel Medical Ventures, LLC
10% Owner -
|
1 016 100 | 50 805 | |
| Gallagher Brian M. Jr. Director - [D] | 1 431 519 | 71 576 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Kathryn Gregory SVP, Chief Business Officer - [O] | 45 000 | 2 250 | |
|
Gullans Steven R. Ph.D.
10% Owner -
|
1 016 100 | 50 805 | |
|
Steven Edward Hall
10% Owner -
|
1 094 987 | 54 749 | |
|
Kck Ltd.
10% Owner -
|
646 817 | 32 341 | |
|
Scott Kapnick
Director, 10% Owner -
[D]
|
66 666 | 3 333 | |
| John P Phd Longenecker President and CEO - [O] | 10 000 | 500 | |
| LV Management Group, LLC - | 1 094 987 | 54 749 | |
|
Lilly Ventures Fund I LLC
10% Owner -
|
1 094 987 | 54 749 | |
| John H Mcarthur | 25 000 | ||
| William Mckee | 12 500 | ||
| Jodie Pope Morrison | 12 500 | ||
|
Ag Novartis
10% Owner -
|
2 079 394 | 103 970 | |
| Kira Nelson | 36 844 | ||
|
Bioventures Ltd Novartis
10% Owner -
|
2 079 394 | 103 970 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
|
Platt Jon B.
10% Owner -
|
90 318 | 4 516 | |
|
Finance Ltd Roche
10% Owner -
|
3 870 | 35 118 | |
|
Holding Ltd Roche
10% Owner -
|
702 363 | 35 118 | |
| Muneer A Satter See Remarks, Director - [D] [O] | 16 609 449 | 830 472 | |
| Armen Shanafelt Director - [D] | 1 094 987 | 54 749 | |
| Nolan Howard Sigal | 12 500 | ||
|
Sigma Emerging Markets Ltd.
10% Owner -
|
423 086 | 21 154 | |
|
Torres S. Edward
10% Owner -
|
1 094 987 | 54 749 | |
|
University Of Texas/texas Am Investment Managment Co
10% Owner -
|
1 746 549 | 1 746 549 | |
| Rickenbach Josef H Von Director - [D] | 445 460 | 22 273 | |
| Vojo Vukovic SVP, Chief Medical Officer - [O] | 75 000 | 3 750 | |
| James Brian Windsor President and CEO - [O] | 161 | 161 | |
| Rick Wanstall | 393 000 | ||
| Caleb Maxfield Winder | 10 000 | ||
|
Yanchik Joseph A., III
See Remarks, Director, 10% Owner -
[D]
[O]
|
247 592 | 12 380 |
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i RNTX / Rein Therapeutics Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i RNTX / Rein Therapeutics Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-09 | 2024-12-05 | 4 | WINDSOR JAMES BRIAN By son | ALRN | Common Stock | I | 2,2500 | 161 | 0 | 161 | ||||
| 2024-12-09 | 2024-12-05 | 4 | WINDSOR JAMES BRIAN By son | ALRN | Common Stock | I | 2,2400 | 239 | 1 | 239 | ||||
| 2024-06-17 | 2024-06-17 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 3,2500 | −4 707 | −15 | 1 746 549 | ||||
| 2024-06-17 | 2024-06-14 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 3,3000 | −1 900 | −6 | 1 751 256 | ||||
| 2024-06-12 | 2024-06-12 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 3,2750 | −1 | −0 | 1 753 156 | ||||
| 2024-06-12 | 2024-06-12 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 3,2500 | −9 341 | −30 | 1 753 157 | ||||
| 2024-06-12 | 2024-06-11 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 3,3500 | −502 | −2 | 1 762 498 | ||||
| 2024-06-12 | 2024-06-11 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 3,2500 | −5 250 | −17 | 1 763 000 | ||||
| 2024-06-12 | 2024-06-10 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 3,3000 | −9 577 | −32 | 1 768 250 | ||||
| 2024-06-07 | 2024-06-07 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 3,3000 | −176 | −1 | 1 777 827 | ||||
| 2024-06-07 | 2024-06-07 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 3,2500 | −1 564 | −5 | 1 778 003 | ||||
| 2024-06-07 | 2024-06-06 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 3,3000 | −3 184 | −11 | 1 779 567 | ||||
| 2024-06-07 | 2024-06-06 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 3,2700 | −1 100 | −4 | 1 782 751 | ||||
| 2024-06-07 | 2024-06-05 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 3,3000 | −6 291 | −21 | 1 783 851 | ||||
| 2024-05-14 | 2024-05-01 | 4/A | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,3200 | −25 | −0 | 1 790 142 | ||||
| 2024-05-14 | 2024-05-01 | 4/A | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,2900 | −2 903 | −12 | 1 790 167 | ||||
| 2024-05-14 | 2024-05-01 | 4/A | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,2850 | −200 | −1 | 1 793 070 | ||||
| 2024-05-14 | 2024-05-01 | 4/A | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,2800 | −337 | −1 | 1 793 270 | ||||
| 2024-05-14 | 2024-05-01 | 4/A | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,2750 | −200 | −1 | 1 793 607 | ||||
| 2024-05-14 | 2024-05-01 | 4/A | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,2700 | −100 | −0 | 1 793 807 | ||||
| 2024-05-14 | 2024-05-01 | 4/A | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,2650 | −317 | −1 | 1 793 907 | ||||
| 2024-05-14 | 2024-05-01 | 4/A | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,2600 | −310 | −1 | 1 794 224 | ||||
| 2024-05-14 | 2024-05-01 | 4/A | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,2500 | −7 923 | −34 | 1 794 534 | ||||
| 2024-05-14 | 2024-05-01 | 4/A | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,1800 | −400 | −2 | 1 802 457 | ||||
| 2024-05-14 | 2024-05-01 | 4/A | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,1500 | −670 | −3 | 1 802 857 | ||||
| 2024-05-14 | 2024-05-01 | 4/A | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,1450 | −1 600 | −7 | 1 803 527 | ||||
| 2024-05-14 | 2024-05-01 | 4/A | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,1300 | −380 | −2 | 1 805 127 | ||||
| 2024-05-14 | 2024-05-01 | 4/A | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,1200 | −1 750 | −7 | 1 805 507 | ||||
| 2024-05-14 | 2024-05-01 | 4/A | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,1100 | −100 | −0 | 1 807 257 | ||||
| 2024-05-14 | 2024-05-01 | 4/A | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,1000 | −3 100 | −13 | 1 807 357 | ||||
| 2024-05-01 | 2024-05-01 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,3200 | −25 | −0 | 1 779 306 | ||||
| 2024-05-01 | 2024-05-01 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,2900 | −2 903 | −12 | 1 779 331 | ||||
| 2024-05-01 | 2024-05-01 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,2850 | −200 | −1 | 1 782 234 | ||||
| 2024-05-01 | 2024-05-01 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,2800 | −337 | −1 | 1 782 434 | ||||
| 2024-05-01 | 2024-05-01 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,2750 | −200 | −1 | 1 782 771 | ||||
| 2024-05-01 | 2024-05-01 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,2700 | −100 | −0 | 1 782 971 | ||||
| 2024-05-01 | 2024-05-01 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,2650 | −317 | −1 | 1 783 071 | ||||
| 2024-05-01 | 2024-05-01 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,2600 | −310 | −1 | 1 783 388 | ||||
| 2024-05-01 | 2024-05-01 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,2500 | −7 923 | −34 | 1 783 698 | ||||
| 2024-05-01 | 2024-05-01 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,1800 | −400 | −2 | 1 791 621 | ||||
| 2024-05-01 | 2024-05-01 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,1500 | −670 | −3 | 1 792 021 | ||||
| 2024-05-01 | 2024-05-01 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,1450 | −1 600 | −7 | 1 792 691 | ||||
| 2024-05-01 | 2024-05-01 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,1300 | −380 | −2 | 1 794 291 | ||||
| 2024-05-01 | 2024-05-01 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,1200 | −1 750 | −7 | 1 794 671 | ||||
| 2024-05-01 | 2024-05-01 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,1100 | −100 | −0 | 1 796 421 | ||||
| 2024-05-01 | 2024-05-01 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,1000 | −3 100 | −13 | 1 796 521 | ||||
| 2024-05-01 | 2024-04-30 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 5,0000 | −45 | −0 | 1 799 621 | ||||
| 2024-05-01 | 2024-04-30 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,9500 | −45 | −0 | 1 799 666 | ||||
| 2024-05-01 | 2024-04-29 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 5,0250 | −448 | −2 | 1 799 711 | ||||
| 2024-05-01 | 2024-04-29 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 5,0050 | −13 | −0 | 1 800 159 | ||||
| 2024-05-01 | 2024-04-29 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 5,0000 | −3 231 | −16 | 1 800 172 | ||||
| 2024-05-01 | 2024-04-29 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,9400 | −100 | −0 | 1 803 403 | ||||
| 2024-05-01 | 2024-04-29 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,9300 | −274 | −1 | 1 803 503 | ||||
| 2024-05-01 | 2024-04-29 | 4 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 4,9200 | −6 680 | −33 | 1 803 777 | ||||
| 2024-04-30 | 3 | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | ALRN | Common Stock | D | 1 810 457 | ||||||||
| 2024-03-06 | 2024-03-05 | 4 | WINDSOR JAMES BRIAN | ALRN | Common Stock | D | 2 000 | 7 122 | ||||||
| 2023-12-18 | 2023-12-15 | 4 | WINDSOR JAMES BRIAN By son | ALRN | Common Stock | I | 3,3700 | 225 | 1 | 225 | ||||
| 2023-11-21 | 2023-11-20 | 4 | WINDSOR JAMES BRIAN | ALRN | Common Stock | D | 1,9675 | 5 076 | 10 | 5 122 | ||||
| 2023-11-02 | 3 | WINDSOR JAMES BRIAN | ALRN | Common Stock | D | 46 | ||||||||
| 2022-03-30 | 2022-03-30 | 4/A | Aivado Manuel | ALRN | Stock Option (right to buy) | D | 0,48 | 1 133 000 | 1 133 000 | |||||
| 2022-03-30 | 2022-03-30 | 4/A | Vukovic Vojo | ALRN | Stock Option (right to buy) | D | 0,48 | 150 000 | 150 000 | |||||
| 2022-03-30 | 2022-03-30 | 4/A | Annis Allen | ALRN | Stock Option (right to buy) | D | 0,48 | 313 000 | 313 000 | |||||
| 2022-03-30 | 2022-03-30 | 4/A | Wanstall Rick | ALRN | Stock Option (right to buy) | D | 0,48 | 393 000 | 393 000 | |||||
| 2022-03-24 | 2022-03-22 | 4 | Annis Allen | ALRN | Stock Option (right to buy) | D | 0,44 | 313 000 | 313 000 | |||||
| 2022-03-24 | 2022-03-22 | 4 | Wanstall Rick | ALRN | Stock Option (right to buy) | D | 0,44 | 393 000 | 393 000 | |||||
| 2022-03-24 | 2022-03-22 | 4 | Aivado Manuel | ALRN | Stock Option (right to buy) | D | 0,44 | 1 133 000 | 1 133 000 | |||||
| 2022-03-24 | 2022-03-22 | 4 | Vukovic Vojo | ALRN | Stock Option (right to buy) | D | 0,44 | 150 000 | 150 000 | |||||
| 2021-06-17 | 2021-06-15 | 4 | Bailey Jeffrey Allen | ALRN | Stock Option (right to buy) | D | 1,29 | 96 000 | 96 000 | |||||
| 2021-06-17 | 2021-06-15 | 4 | Aivado Manuel | ALRN | Stock Option (right to buy) | D | 1,29 | 2 440 000 | 2 440 000 | |||||
| 2021-06-17 | 2021-06-15 | 4 | Wanstall Rick | ALRN | Stock Option (right to buy) | D | 1,29 | 600 000 | 600 000 | |||||
| 2021-06-17 | 2021-06-15 | 4 | Ambros Reinhard J. | ALRN | Stock Option (right to buy) | D | 1,29 | 96 000 | 96 000 | |||||
| 2021-06-17 | 2021-06-15 | 4 | Morrison Jodie Pope | ALRN | Stock Option (right to buy) | D | 1,29 | 96 000 | 96 000 | |||||
| 2021-06-17 | 2021-06-15 | 4 | MCKEE WILLIAM | ALRN | Stock Option (right to buy) | D | 1,29 | 96 000 | 96 000 | |||||
| 2021-06-17 | 2021-06-15 | 4 | Sigal Nolan Howard | ALRN | Stock Option (right to buy) | D | 1,29 | 96 000 | 96 000 | |||||
| 2021-06-17 | 2021-06-15 | 4 | Vukovic Vojo | ALRN | Stock Option (right to buy) | D | 1,29 | 400 000 | 400 000 | |||||
| 2021-06-17 | 2021-06-15 | 4 | VON RICKENBACH JOSEF H | ALRN | Stock Option (right to buy) | D | 1,29 | 96 000 | 96 000 | |||||
| 2021-06-17 | 2021-06-15 | 4 | Annis Allen | ALRN | Stock Option (right to buy) | D | 1,29 | 474 000 | 474 000 | |||||
| 2021-01-08 | 2021-01-08 | 4 | Satter Muneer A | ALRN | Common Stock | I | 1,1000 | 9 000 000 | 9 900 | 16 609 449 | ||||
| 2020-06-24 | 2020-06-23 | 4 | Wanstall Rick | ALRN | Stock Option (right to buy) | D | 1,20 | 91 000 | 91 000 | |||||
| 2020-06-18 | 2020-06-17 | 4 | Ambros Reinhard J. | ALRN | Stock Option (right to buy) | D | 1,15 | 12 500 | 12 500 | |||||
| 2020-06-18 | 2020-06-17 | 4 | Bailey Jeffrey Allen | ALRN | Stock Option (right to buy) | D | 1,15 | 12 500 | 12 500 | |||||
| 2020-06-18 | 2020-06-17 | 4 | Morrison Jodie Pope | ALRN | Stock Option (right to buy) | D | 1,15 | 12 500 | 12 500 | |||||
| 2020-06-18 | 2020-06-17 | 4 | MCKEE WILLIAM | ALRN | Stock Option (right to buy) | D | 1,15 | 12 500 | 12 500 | |||||
| 2020-06-18 | 2020-06-17 | 4 | VON RICKENBACH JOSEF H | ALRN | Stock Option (right to buy) | D | 1,15 | 12 500 | 12 500 | |||||
| 2020-06-18 | 2020-06-17 | 4 | Sigal Nolan Howard | ALRN | Stock Option (right to buy) | D | 1,15 | 12 500 | 12 500 | |||||
| 2020-06-17 | 2020-06-15 | 4 | Ambros Reinhard J. | ALRN | Common Stock | D | 1,2200 | 5 800 | 7 | 5 800 | ||||
| 2020-06-09 | 2020-06-08 | 4 | Satter Muneer A | ALRN | Common Stock | I | 1,1000 | 3 700 000 | 4 070 | 7 609 449 | ||||
| 2020-06-09 | 2020-06-08 | 4 | VON RICKENBACH JOSEF H | ALRN | Common Stock | D | 1,1000 | 227 272 | 250 | 445 460 | ||||
| 2020-02-04 | 2020-01-31 | 4 | Wanstall Rick | ALRN | Stock Option (right to buy) | D | 0,67 | 200 000 | 200 000 | |||||
| 2020-02-04 | 2020-01-31 | 4 | Gregory Kathryn | ALRN | Stock Option (right to buy) | D | 0,67 | 185 000 | 185 000 | |||||
| 2020-02-04 | 2020-01-31 | 4 | Aivado Manuel | ALRN | Stock Option (right to buy) | D | 0,67 | −400 000 | 400 000 | |||||
| 2020-02-04 | 2020-01-31 | 4 | Vukovic Vojo | ALRN | Stock Option (right to buy) | D | 0,67 | 225 000 | 225 000 | |||||
| 2020-02-04 | 2020-01-31 | 4 | Annis Allen | ALRN | Stock Option (right to buy) | D | 0,67 | 125 000 | 125 000 | |||||
| 2019-11-18 | 2019-11-15 | 4 | Bailey Jeffrey Allen | ALRN | Common Stock | D | 0,5100 | 39 142 | 20 | 74 894 | ||||
| 2019-11-18 | 2019-11-14 | 4 | Bailey Jeffrey Allen | ALRN | Common Stock | D | 0,5100 | 15 858 | 8 | 35 752 | ||||
| 2019-11-14 | 2019-11-12 | 4 | Bailey Jeffrey Allen | ALRN | Common Stock | D | 0,5300 | 19 894 | 11 | 19 894 | ||||
| 2019-09-16 | 2019-09-13 | 4 | VON RICKENBACH JOSEF H | ALRN | Common Stock | D | 0,9702 | 25 000 | 24 | 218 188 | ||||
| 2019-09-16 | 2019-09-12 | 4 | VON RICKENBACH JOSEF H | ALRN | Common Stock | D | 0,9785 | 88 145 | 86 | 193 188 | ||||
| 2019-09-05 | 2019-09-04 | 4 | VON RICKENBACH JOSEF H | ALRN | Common Stock | D | 0,7140 | 23 225 | 17 | 105 043 | ||||
| 2019-09-04 | 2019-09-03 | 4 | VON RICKENBACH JOSEF H | ALRN | Common Stock | D | 0,7001 | 13 466 | 9 | 81 818 | ||||
| 2019-09-04 | 2019-08-30 | 4 | VON RICKENBACH JOSEF H | ALRN | Common Stock | D | 0,7312 | 15 000 | 11 | 68 352 | ||||
| 2019-09-03 | 2019-08-29 | 4 | VON RICKENBACH JOSEF H | ALRN | Common Stock | D | 0,7697 | 3 600 | 3 | 53 352 | ||||
| 2019-08-20 | 2019-08-16 | 4 | Vukovic Vojo | ALRN | Common Stock | D | 0,5927 | 75 000 | 44 | 75 000 | ||||
| 2019-08-15 | 2019-08-13 | 4 | Gregory Kathryn | ALRN | Common Stock | D | 0,6450 | 45 000 | 29 | 45 000 | ||||
| 2019-06-24 | 2019-06-19 | 4 | VON RICKENBACH JOSEF H | ALRN | Stock Option (right to buy) | D | 0,86 | 25 000 | 25 000 | |||||
| 2019-06-24 | 3 | VON RICKENBACH JOSEF H | ALRN | Common Stock | D | 99 504 | ||||||||
| 2019-06-24 | 3 | VON RICKENBACH JOSEF H | ALRN | Common Stock | D | 99 504 | ||||||||
| 2019-06-24 | 3 | VON RICKENBACH JOSEF H | ALRN | Common Stock | D | 99 504 | ||||||||
| 2019-06-24 | 2019-06-19 | 4 | MCKEE WILLIAM | ALRN | Stock Option (right to buy) | D | 0,86 | 25 000 | 25 000 | |||||
| 2019-06-21 | 2019-06-19 | 4 | Bailey Jeffrey Allen | ALRN | Stock Option (right to buy) | D | 0,86 | 50 000 | 50 000 | |||||
| 2019-06-21 | 2019-06-19 | 4 | Ambros Reinhard J. | ALRN | Stock Option (right to buy) | D | 0,86 | 50 000 | 50 000 | |||||
| 2019-06-21 | 2019-06-19 | 4 | Morrison Jodie Pope | ALRN | Stock Option (right to buy) | D | 0,86 | 25 000 | 25 000 | |||||
| 2019-06-21 | 2019-06-19 | 4 | Sigal Nolan Howard | ALRN | Stock Option (right to buy) | D | 0,86 | 5 000 | 5 000 | |||||
| 2019-06-21 | 2019-06-19 | 4 | MCARTHUR JOHN H | ALRN | Stock Option (right to buy) | D | 0,86 | 25 000 | 25 000 | |||||
| 2019-04-17 | 2019-04-15 | 4 | Gregory Kathryn | ALRN | Stock Option (right to buy) | D | 1,75 | 20 000 | 20 000 | |||||
| 2019-04-17 | 2019-04-15 | 4 | Annis Allen | ALRN | Stock Option (right to buy) | D | 1,75 | 100 000 | 100 000 | |||||
| 2019-04-17 | 2019-04-15 | 4 | Aivado Manuel | ALRN | Stock Option (right to buy) | D | 1,75 | 500 000 | 500 000 | |||||
| 2019-04-17 | 2019-04-15 | 4 | Vukovic Vojo | ALRN | Stock Option (right to buy) | D | 1,75 | 100 000 | 100 000 | |||||
| 2019-04-17 | 2019-04-15 | 4 | Dougherty Donald | ALRN | Stock Option (right to buy) | D | 1,75 | 150 000 | 150 000 | |||||
| 2019-04-17 | 2019-04-15 | 4 | Wanstall Rick | ALRN | Stock Option (right to buy) | D | 1,75 | 59 000 | 59 000 | |||||
| 2019-04-03 | 3 | Satter Muneer A | ALRN | Common Stock | I | 7 818 898 | ||||||||
| 2019-04-03 | 3 | Satter Muneer A | ALRN | Common Stock | I | 7 818 898 | ||||||||
| 2019-04-03 | 3 | Satter Muneer A | ALRN | Common Stock | I | 7 818 898 | ||||||||
| 2019-04-03 | 2019-04-02 | 4 | Sigal Nolan Howard | ALRN | Stock Option (right to buy) | D | 1,82 | 20 000 | 20 000 | |||||
| 2019-04-02 | 2019-04-01 | 4 | Novartis Bioventures Ltd | ALRN | Common Stock | D | 1,9000 | −20 610 | −39 | 2 079 394 | ||||
| 2019-04-02 | 2019-03-29 | 4 | Novartis Bioventures Ltd | ALRN | Common Stock | D | 1,8500 | −106 540 | −197 | 2 100 004 | ||||
| 2019-03-15 | 2019-03-15 | 4 | Novartis Bioventures Ltd | ALRN | Common Stock | D | 1,9200 | −43 800 | −84 | 2 206 544 | ||||
| 2019-03-15 | 2019-03-14 | 4 | Novartis Bioventures Ltd | ALRN | Common Stock | D | 1,8800 | −13 800 | −26 | 2 250 344 | ||||
| 2019-03-15 | 2019-03-13 | 4 | Novartis Bioventures Ltd | ALRN | Common Stock | D | 2,1200 | −132 738 | −281 | 2 264 144 | ||||
| 2019-02-25 | 2019-02-25 | 4 | Gregory Kathryn | ALRN | Stock Option (right to buy) | D | 1,47 | 100 000 | 100 000 | |||||
| 2018-11-06 | 2018-11-05 | 4 | Vukovic Vojo | ALRN | Stock Option (right to buy) | D | 2,16 | 150 000 | 150 000 | |||||
| 2018-11-06 | 3 | Annis Allen | ALRN | Common Stock | D | 15 094 | ||||||||
| 2018-11-06 | 3 | Annis Allen | ALRN | Common Stock | D | 15 094 | ||||||||
| 2018-09-07 | 2018-09-06 | 4 | Aivado Manuel | ALRN | Stock Option (right to buy) | D | 3,39 | 232 914 | 232 914 | |||||
| 2018-08-22 | 2018-08-20 | 4 | Novartis Bioventures Ltd | ALRN | Common Stock | D | 2,3000 | −20 388 | −47 | 2 396 882 | ||||
| 2018-08-20 | 2018-08-17 | 4 | Novartis Bioventures Ltd | ALRN | Common Stock | D | 2,1000 | −8 700 | −18 | 2 417 270 | ||||
| 2018-08-20 | 2018-08-16 | 4 | Novartis Bioventures Ltd | ALRN | Common Stock | D | 2,1000 | −8 808 | −18 | 2 425 970 | ||||
| 2018-08-16 | 2018-08-15 | 4 | Novartis Bioventures Ltd | ALRN | Common Stock | D | 2,1500 | −2 635 | −6 | 2 434 778 | ||||
| 2018-08-16 | 2018-08-14 | 4 | Novartis Bioventures Ltd | ALRN | Common Stock | D | 2,2600 | −3 300 | −7 | 2 437 413 | ||||
| 2018-08-14 | 2017-07-05 | 4/A | Kapnick Scott | ALRN | Common Stock | I | 15,0000 | 66 666 | 1 000 | 66 666 | ||||
| 2018-08-14 | 2018-08-10 | 4 | LONGENECKER JOHN P PHD | ALRN | Common Stock | D | 2,4500 | 10 000 | 24 | 10 000 | ||||
| 2018-08-14 | 2018-08-13 | 4 | Novartis Bioventures Ltd | ALRN | Common Stock | D | 2,3600 | −1 600 | −4 | 2 440 713 | ||||
| 2018-08-14 | 2018-08-10 | 4 | Novartis Bioventures Ltd | ALRN | Common Stock | D | 2,4400 | −5 615 | −14 | 2 442 313 | ||||
| 2018-08-10 | 2018-08-09 | 4 | Novartis Bioventures Ltd | ALRN | Common Stock | D | 2,4800 | −235 | −1 | 2 447 928 | ||||
| 2018-08-10 | 2018-08-08 | 4 | Novartis Bioventures Ltd | ALRN | Common Stock | D | 2,7800 | −1 000 | −3 | 2 448 163 | ||||
| 2018-08-08 | 2018-08-07 | 4 | Novartis Bioventures Ltd | ALRN | Common Stock | D | 2,9700 | −1 739 | −5 | 2 449 163 | ||||
| 2018-08-08 | 2018-08-06 | 4 | Novartis Bioventures Ltd | ALRN | Common Stock | D | 3,0200 | −2 942 | −9 | 2 450 902 | ||||
| 2018-08-06 | 2018-08-02 | 4 | Novartis Bioventures Ltd | ALRN | Common Stock | D | 3,3300 | −4 702 | −16 | 2 453 844 | ||||
| 2018-08-02 | 2018-08-01 | 4 | Novartis Bioventures Ltd | ALRN | Common Stock | D | 3,2200 | −8 181 | −26 | 2 458 546 | ||||
| 2018-08-02 | 2018-07-31 | 4 | Novartis Bioventures Ltd | ALRN | Common Stock | D | 3,0700 | −4 500 | −14 | 2 466 727 | ||||
| 2018-07-31 | 2018-07-30 | 4 | Novartis Bioventures Ltd | ALRN | Common Stock | D | 3,2700 | −2 000 | −7 | 2 471 227 | ||||
| 2018-07-31 | 2018-07-27 | 4 | Novartis Bioventures Ltd | ALRN | Common Stock | D | 3,3800 | −6 458 | −22 | 2 473 227 | ||||
| 2018-07-27 | 2018-07-26 | 4 | Novartis Bioventures Ltd | ALRN | Common Stock | D | 3,6300 | −7 937 | −29 | 2 479 685 | ||||
| 2018-07-27 | 2018-07-25 | 4 | Novartis Bioventures Ltd | ALRN | Common Stock | D | 3,8400 | −12 460 | −48 | 2 487 622 | ||||
| 2018-07-25 | 2018-07-24 | 4 | Novartis Bioventures Ltd | ALRN | Common Stock | D | 4,1100 | −700 | −3 | 2 500 082 | ||||
| 2018-07-25 | 2018-07-23 | 4 | Novartis Bioventures Ltd | ALRN | Common Stock | D | 4,2500 | −30 600 | −130 | 2 500 782 | ||||
| 2018-07-18 | 2018-07-17 | 4 | Novartis Bioventures Ltd | ALRN | Common Stock | D | 4,7100 | −12 500 | −59 | 2 531 382 | ||||
| 2018-07-18 | 2018-07-16 | 4 | Novartis Bioventures Ltd | ALRN | Common Stock | D | 5,1500 | −300 | −2 | 2 543 882 | ||||
| 2018-07-10 | 2018-07-06 | 4 | APPLE TREE PARTNERS II LP | ALRN | Common Stock | D | −1 380 241 | 0 | ||||||
| 2018-07-10 | 2018-07-06 | 4 | Apple Tree Partners II - Annex, L.P. | ALRN | Common Stock | D | −655 797 | 0 | ||||||
| 2018-06-26 | 2018-06-26 | 4 | APPLE TREE PARTNERS II LP | ALRN | Common Stock | D | 5,4545 | −10 528 | −57 | 1 380 241 | ||||
| 2018-06-26 | 2018-06-25 | 4 | APPLE TREE PARTNERS II LP | ALRN | Common Stock | D | 5,8631 | −913 | −5 | 1 390 769 | ||||
| 2018-06-26 | 2018-06-22 | 4 | APPLE TREE PARTNERS II LP | ALRN | Common Stock | D | 5,9773 | −94 816 | −567 | 1 391 682 | ||||
| 2018-06-25 | 2018-06-21 | 4 | Morrison Jodie Pope | ALRN | Stock Option (right to buy) | D | 6,02 | 10 000 | 10 000 | |||||
| 2018-06-25 | 2018-06-21 | 4 | Shanafelt Armen | ALRN | Stock Option (right to buy) | D | 6,02 | 10 000 | 10 000 | |||||
| 2018-06-25 | 2018-06-21 | 4 | MCARTHUR JOHN H | ALRN | Stock Option (right to buy) | D | 6,02 | 10 000 | 10 000 | |||||
| 2018-06-25 | 2018-06-21 | 4 | Winder Caleb Maxfield | ALRN | Stock Option (right to buy) | D | 6,02 | 10 000 | 10 000 | |||||
| 2018-06-25 | 2018-06-21 | 4 | Ambros Reinhard J. | ALRN | Stock Option (right to buy) | D | 6,02 | 10 000 | 10 000 | |||||
| 2018-06-25 | 2018-06-21 | 4 | Bailey Jeffrey Allen | ALRN | Stock Option (right to buy) | D | 6,02 | 10 000 | 10 000 | |||||
| 2018-06-21 | 2018-06-21 | 4 | APPLE TREE PARTNERS II LP | ALRN | Common Stock | D | 5,3000 | −1 447 | −8 | 1 486 498 | ||||
| 2018-06-21 | 2018-06-20 | 4 | APPLE TREE PARTNERS II LP | ALRN | Common Stock | D | 5,3007 | −5 200 | −28 | 1 487 945 | ||||
| 2018-06-19 | 2018-06-19 | 4 | APPLE TREE PARTNERS II LP | ALRN | Common Stock | D | 5,3000 | −139 | −1 | 1 493 145 | ||||
| 2018-06-19 | 2018-06-18 | 4 | APPLE TREE PARTNERS II LP | ALRN | Common Stock | D | 5,3500 | −1 432 | −8 | 1 493 284 | ||||
| 2018-06-19 | 2018-06-15 | 4 | APPLE TREE PARTNERS II LP | ALRN | Common Stock | D | 5,3191 | −7 961 | −42 | 1 494 716 | ||||
| 2018-06-14 | 2018-06-12 | 4 | APPLE TREE PARTNERS II LP | ALRN | Common Stock | D | 5,4005 | −10 843 | −59 | 1 502 677 | ||||
| 2018-06-12 | 2018-06-08 | 4 | Dougherty Donald | ALRN | Common Stock | D | 5,4000 | 3 000 | 16 | 5 000 | ||||
| 2018-06-11 | 2018-06-11 | 4 | APPLE TREE PARTNERS II LP | ALRN | Common Stock | D | 5,4112 | −18 525 | −100 | 1 513 520 | ||||
| 2018-06-11 | 2018-06-08 | 4 | APPLE TREE PARTNERS II LP | ALRN | Common Stock | D | 5,4032 | −9 617 | −52 | 1 532 045 | ||||
| 2018-06-11 | 2018-06-07 | 4 | APPLE TREE PARTNERS II LP | ALRN | Common Stock | D | 5,4750 | −20 | −0 | 1 541 662 | ||||
| 2018-06-08 | 2018-06-06 | 4 | Aivado Manuel | ALRN | Common Stock | D | 5,6100 | 1 000 | 6 | 1 000 | ||||
| 2018-06-04 | 2018-06-01 | 4 | Dougherty Donald | ALRN | Common Stock | D | 5,2400 | 2 000 | 10 | 2 000 | ||||
| 2018-05-17 | 2018-05-15 | 4 | LONGENECKER JOHN P PHD | ALRN | Stock Option (right to buy) | D | 5,50 | 30 000 | 30 000 | |||||
| 2018-04-19 | 2018-04-19 | 4 | APPLE TREE PARTNERS II LP | ALRN | Common Stock | D | 6,2930 | −104 799 | −660 | 1 541 682 | ||||
| 2018-04-19 | 2018-04-17 | 4 | APPLE TREE PARTNERS II LP | ALRN | Common Stock | D | 7,0500 | −3 105 | −22 | 1 646 481 | ||||
| 2018-03-19 | 2018-03-15 | 4 | Bailey Jeffrey Allen | ALRN | Stock Option (right to buy) | D | 9,02 | 20 000 | 20 000 | |||||
| 2018-01-11 | 2018-01-09 | 4 | APPLE TREE PARTNERS II LP | ALRN | Common Stock | D | 9,8029 | −150 000 | −1 470 | 1 649 586 | ||||
| 2017-09-28 | 2017-09-26 | 4 | Ambros Reinhard J. | ALRN | Stock Option (right to buy) | D | 12,09 | 20 000 | 20 000 | |||||
| 2017-07-27 | 2017-07-25 | 4 | Nelson Kira | ALRN | Stock Option (right to buy) | D | 13,00 | 36 844 | 36 844 | |||||
| 2017-07-27 | 2017-07-25 | 4 | Yanchik Joseph A., III | ALRN | Stock Option (right to buy) | D | 13,00 | 157 449 | 157 449 | |||||
| 2017-07-27 | 2017-07-25 | 4 | Aivado Manuel | ALRN | Stock Option (right to buy) | D | 13,00 | 57 388 | 57 388 | |||||
| 2017-07-27 | 2017-07-25 | 4 | MCARTHUR JOHN H | ALRN | Stock Option (right to buy) | D | 13,00 | 20 000 | 20 000 | |||||
| 2017-07-27 | 2017-07-25 | 4 | Shanafelt Armen | ALRN | Stock Option (right to buy) | D | 13,00 | 20 000 | 20 000 | |||||
| 2017-07-27 | 2017-07-25 | 4 | Dougherty Donald | ALRN | Stock Option (right to buy) | D | 13,00 | 60 331 | 60 331 | |||||
| 2017-07-27 | 2017-07-25 | 4 | Gallagher Brian M. Jr. | ALRN | Stock Option (right to buy) | D | 13,00 | 20 000 | 20 000 | |||||
| 2017-07-27 | 2017-07-25 | 4 | Morrison Jodie Pope | ALRN | Stock Option (right to buy) | D | 13,00 | 20 000 | 20 000 | |||||
| 2017-07-27 | 2017-07-25 | 4 | Kapnick Scott | ALRN | Stock Option (right to buy) | D | 13,00 | 20 000 | 20 000 | |||||
| 2017-07-27 | 2017-07-25 | 4 | Winder Caleb Maxfield | ALRN | Stock Option (right to buy) | D | 13,00 | 20 000 | 20 000 | |||||
| 2017-07-07 | 2017-07-05 | 4 | Apple Tree Partners II - Annex, L.P. | ALRN | Series E-1 Preferred Stock | D | −3 026 920 | 0 | ||||||
| 2017-07-07 | 2017-07-05 | 4 | Apple Tree Partners II - Annex, L.P. | ALRN | Series E Preferred Stock | D | −3 489 740 | 0 | ||||||
| 2017-07-07 | 2017-07-05 | 4 | Apple Tree Partners II - Annex, L.P. | ALRN | Common Stock | D | 655 797 | 655 797 | ||||||
| 2017-07-07 | 2017-07-05 | 4 | APPLE TREE PARTNERS II LP | ALRN | Series D Preferred Stock | D | −6 781 770 | 0 | ||||||
| 2017-07-07 | 2017-07-05 | 4 | APPLE TREE PARTNERS II LP | ALRN | Series C-2 Preferred Stock | D | −4 238 607 | 0 | ||||||
| 2017-07-07 | 2017-07-05 | 4 | APPLE TREE PARTNERS II LP | ALRN | Series C-1 Preferred Stock | D | −2 967 025 | 0 | ||||||
| 2017-07-07 | 2017-07-05 | 4 | APPLE TREE PARTNERS II LP | ALRN | Series B Preferred Stock | D | −3 706 056 | 0 | ||||||
| 2017-07-07 | 2017-07-05 | 4 | APPLE TREE PARTNERS II LP | ALRN | Series A-1 Preferred Stock | D | −615 384 | 0 | ||||||
| 2017-07-07 | 2017-07-05 | 4 | APPLE TREE PARTNERS II LP | ALRN | Series A Preferred Stock | D | −1 250 000 | 0 | ||||||
| 2017-07-07 | 2017-07-05 | 4 | APPLE TREE PARTNERS II LP | ALRN | Common Stock | D | 1 780 564 | 1 799 586 | ||||||
| 2017-07-07 | 2017-07-05 | 4 | APPLE TREE PARTNERS II LP | ALRN | Common Stock | D | 18 771 | 19 022 | ||||||
| 2017-07-07 | 2017-07-05 | 4 | LV Management Group, LLC By Fund | ALRN | Series F Preferred Stock | I | −1 443 972 | 0 | ||||||
| 2017-07-07 | 2017-07-05 | 4 | LV Management Group, LLC By Fund | ALRN | Series E-3 Preferred Stock | I | −1 654 411 | 0 | ||||||
| 2017-07-07 | 2017-07-05 | 4 | LV Management Group, LLC By Fund | ALRN | Series E-2 Preferred Stock | I | −1 907 373 | 0 | ||||||
| 2017-07-07 | 2017-07-05 | 4 | LV Management Group, LLC By Fund | ALRN | Series D Preferred Stock | I | −3 390 885 | 0 | ||||||
| 2017-07-07 | 2017-07-05 | 4 | LV Management Group, LLC By Fund | ALRN | Common Stock | I | 15,0000 | 250 000 | 3 750 | 1 094 987 | ||||
| 2017-07-07 | 2017-07-05 | 4 | LV Management Group, LLC By Fund | ALRN | Common Stock | I | 844 987 | 844 987 | ||||||
| 2017-07-07 | 2017-07-05 | 4 | Shanafelt Armen | ALRN | Series F Preferred Stock | I | −1 443 972 | 0 | ||||||
| 2017-07-07 | 2017-07-05 | 4 | Shanafelt Armen | ALRN | Series E-3 Preferred Stock | I | −1 654 411 | 0 | ||||||
| 2017-07-07 | 2017-07-05 | 4 | Shanafelt Armen | ALRN | Series E-2 Preferred Stock | I | −1 907 373 | 0 | ||||||
| 2017-07-07 | 2017-07-05 | 4 | Shanafelt Armen | ALRN | Series D Preferred Stock | I | −3 390 885 | 0 | ||||||
| 2017-07-07 | 2017-07-05 | 4 | Shanafelt Armen | ALRN | Common Stock | I | 15,0000 | 250 000 | 3 750 | 1 094 987 | ||||
| 2017-07-07 | 2017-07-05 | 4 | Shanafelt Armen | ALRN | Common Stock | I | 844 987 | 844 987 | ||||||
| 2017-07-07 | 2017-07-05 | 4 | AJU IB Investment Co., Ltd. | ALRN | Series F Preferred Stock | I | −483 501 | 0 | ||||||
| 2017-07-07 | 2017-07-05 | 4 | AJU IB Investment Co., Ltd. | ALRN | Series E-3 Preferred Stock | I | −4 411 765 | 0 | ||||||
| 2017-07-07 | 2017-07-05 | 4 | AJU IB Investment Co., Ltd. | ALRN | Common Stock | I | 15,0000 | 24 929 | 374 | 517 558 | ||||
| 2017-07-07 | 2017-07-05 | 4 | AJU IB Investment Co., Ltd. | ALRN | Common Stock | I | 48 656 | 492 629 | ||||||
| 2017-07-07 | 2017-07-05 | 4 | AJU IB Investment Co., Ltd. | ALRN | Common Stock | I | 443 973 | 443 973 | ||||||
| 2017-07-06 | 2017-07-05 | 4 | Sigma Emerging Markets Ltd. | ALRN | Series F Preferred Stock | D | −2 316 176 | 0 | ||||||
| 2017-07-06 | 2017-07-05 | 4 | Sigma Emerging Markets Ltd. | ALRN | Common Stock | D | 15,0000 | 190 000 | 2 850 | 423 086 | ||||
| 2017-07-06 | 2017-07-05 | 4 | Sigma Emerging Markets Ltd. | ALRN | Common Stock | D | 233 086 | 233 086 | ||||||
| 2017-07-06 | 2017-07-05 | 4 | Gallagher Brian M. Jr. | ALRN | Series F Preferred Stock | I | −1 979 188 | 0 | ||||||
| 2017-07-06 | 2017-07-05 | 4 | Gallagher Brian M. Jr. | ALRN | Series E-3 Preferred Stock | I | −1 276 389 | 0 | ||||||
| 2017-07-06 | 2017-07-05 | 4 | Gallagher Brian M. Jr. | ALRN | Series E-2 Preferred Stock | I | −1 471 551 | 0 | ||||||
| 2017-07-06 | 2017-07-05 | 4 | Gallagher Brian M. Jr. | ALRN | Series D Preferred Stock | I | −6 781 770 | 0 | ||||||
| 2017-07-06 | 2017-07-05 | 4 | Gallagher Brian M. Jr. | ALRN | Common Stock | I | 15,0000 | 273 333 | 4 100 | 1 431 519 | ||||
| 2017-07-06 | 2017-07-05 | 4 | Gallagher Brian M. Jr. | ALRN | Common Stock | I | 1 158 186 | 1 158 186 | ||||||
| 2017-07-06 | 2017-07-05 | 4 | Satter Muneer A | ALRN | Series F Preferred Stock | I | −247 398 | 0 | ||||||
| 2017-07-06 | 2017-07-05 | 4 | Satter Muneer A | ALRN | Series E-3 Preferred Stock | I | −159 548 | 0 | ||||||
| 2017-07-06 | 2017-07-05 | 4 | Satter Muneer A | ALRN | Series E-2 Preferred Stock | I | −183 944 | 0 | ||||||
| 2017-07-06 | 2017-07-05 | 4 | Satter Muneer A | ALRN | Series D Preferred Stock | I | −847 721 | 0 | ||||||
| 2017-07-06 | 2017-07-05 | 4 | Satter Muneer A | ALRN | Common Stock | I | 15,0000 | 33 333 | 500 | 178 106 | ||||
| 2017-07-06 | 2017-07-05 | 4 | Satter Muneer A | ALRN | Common Stock | I | 144 773 | 144 773 | ||||||
| 2017-07-06 | 2017-07-05 | 4 | EXCEL MEDICAL FUND LP | ALRN | Series F Preferred Stock | D | −1 083 119 | 0 | ||||||
| 2017-07-06 | 2017-07-05 | 4 | EXCEL MEDICAL FUND LP | ALRN | Series E-3 Preferred Stock | D | −1 153 606 | 0 | ||||||
| 2017-07-06 | 2017-07-05 | 4 | EXCEL MEDICAL FUND LP | ALRN | Series E-2 Preferred Stock | D | −1 329 993 | 0 | ||||||
| 2017-07-06 | 2017-07-05 | 4 | EXCEL MEDICAL FUND LP | ALRN | Series D Preferred Stock | D | −5 934 050 | 0 | ||||||
| 2017-07-06 | 2017-07-05 | 4 | EXCEL MEDICAL FUND LP | ALRN | Common Stock | D | 15,0000 | 60 000 | 900 | 1 016 100 | ||||
| 2017-07-06 | 2017-07-05 | 4 | EXCEL MEDICAL FUND LP | ALRN | Common Stock | D | 956 100 | 956 100 | ||||||
| 2017-07-05 | 3/A | ROCHE FINANCE LTD | ALRN | Common Stock | I | 3 870 | ||||||||
| 2017-07-05 | 2017-07-05 | 4 | Kapnick Scott | ALRN | Series F Preferred Stock | D | −487 776 | 0 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | Kapnick Scott | ALRN | Series E-3 Preferred Stock | D | −1 266 130 | 0 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | Kapnick Scott | ALRN | Series E-2 Preferred Stock | D | −612 002 | 0 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | Kapnick Scott | ALRN | Series D-1 Preferred Stock | D | −363 636 | 0 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | Kapnick Scott | ALRN | Series D Preferred Stock | D | −106 856 | 0 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | Kapnick Scott | ALRN | Common Stock | I | 15,0000 | 66 666 | 1 000 | 521 049 | ||||
| 2017-07-05 | 2017-07-05 | 4 | Kapnick Scott | ALRN | Common Stock | D | 15,0000 | 159 307 | 2 390 | 454 383 | ||||
| 2017-07-05 | 2017-07-05 | 4 | Kapnick Scott | ALRN | Common Stock | D | 285 438 | 295 076 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | CVF, LLC | ALRN | Series F Preferred Stock | D | −916 262 | 0 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | CVF, LLC | ALRN | Series E-3 Preferred Stock | D | −4 411 765 | 0 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | CVF, LLC | ALRN | Common Stock | D | 15,0000 | 180 000 | 2 700 | 716 180 | ||||
| 2017-07-05 | 2017-07-05 | 4 | CVF, LLC | ALRN | Common Stock | D | 536 180 | 536 180 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | ROCHE HOLDING LTD | ALRN | Series F Preferred Stock | D | −989 594 | 0 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | ROCHE HOLDING LTD | ALRN | Series E-3 Preferred Stock | D | −638 194 | 0 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | ROCHE HOLDING LTD | ALRN | Series E-2 Preferred Stock | D | −735 775 | 0 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | ROCHE HOLDING LTD | ALRN | Series D Preferred Stock | D | −3 390 885 | 0 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | ROCHE HOLDING LTD | ALRN | Common Stock | D | 15,0000 | 119 400 | 1 791 | 702 363 | ||||
| 2017-07-05 | 2017-07-05 | 4 | ROCHE HOLDING LTD | ALRN | Common Stock | D | 579 093 | 582 963 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | Platt Jon B. | ALRN | Series E-1 Preferred Stock | D | −258 912 | 0 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | Platt Jon B. | ALRN | Series E Preferred Stock | D | −298 500 | 0 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | Platt Jon B. | ALRN | Series D Preferred Stock | D | −127 158 | 0 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | Platt Jon B. | ALRN | Series C-2 Preferred Stock | D | −211 930 | 0 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | Platt Jon B. | ALRN | Common Stock | D | 90 218 | 90 318 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | KCK LTD. | ALRN | Series F Preferred Stock | D | −763 552 | 0 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | KCK LTD. | ALRN | Series E-3 Preferred Stock | D | −3 676 471 | 0 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | KCK LTD. | ALRN | Common Stock | D | 15,0000 | 200 000 | 3 000 | 646 817 | ||||
| 2017-07-05 | 2017-07-05 | 4 | KCK LTD. | ALRN | Common Stock | D | 446 817 | 446 817 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | Ambros Reinhard J. | ALRN | Series F Preferred Stock | I | −3 705 882 | 0 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | Ambros Reinhard J. | ALRN | Series E-3 Preferred Stock | I | −2 293 829 | 0 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | Ambros Reinhard J. | ALRN | Series E-2 Preferred Stock | I | −2 644 558 | 0 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | Ambros Reinhard J. | ALRN | Series D Preferred Stock | I | −6 781 770 | 0 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | Ambros Reinhard J. | ALRN | Series C-2 Preferred Stock | I | −4 238 607 | 0 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | Ambros Reinhard J. | ALRN | Series C Preferred Stock | I | −2 967 025 | 0 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | Ambros Reinhard J. | ALRN | Common Stock | I | 15,0000 | 266 667 | 4 000 | 2 544 182 | ||||
| 2017-07-05 | 2017-07-05 | 4 | Ambros Reinhard J. | ALRN | Common Stock | I | 2 277 515 | 2 277 515 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | Novartis Bioventures Ltd | ALRN | Series F Preferred Stock | D | −3 705 882 | 0 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | Novartis Bioventures Ltd | ALRN | Series E-3 Preferred Stock | D | −2 293 829 | 0 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | Novartis Bioventures Ltd | ALRN | Series E-2 Preferred Stock | D | −2 644 558 | 0 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | Novartis Bioventures Ltd | ALRN | Series D Preferred Stock | D | −6 781 770 | 0 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | Novartis Bioventures Ltd | ALRN | Series C-2 Preferred Stock | D | −4 238 607 | 0 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | Novartis Bioventures Ltd | ALRN | Series C Preferred Stock | D | −2 967 025 | 0 | ||||||
| 2017-07-05 | 2017-07-05 | 4 | Novartis Bioventures Ltd | ALRN | Common Stock | D | 15,0000 | 266 667 | 4 000 | 2 544 182 | ||||
| 2017-07-05 | 2017-07-05 | 4 | Novartis Bioventures Ltd | ALRN | Common Stock | D | 2 277 515 | 2 277 515 | ||||||
| 2017-06-30 | 2017-06-28 | 4 | Dougherty Donald | ALRN | Stock Option (right to buy) | D | 15,00 | 140 887 | 140 887 | |||||
| 2017-06-28 | 3 | Kapnick Scott | ALRN | Common Stock | D | 19 276 | ||||||||
| 2017-06-28 | 3 | Kapnick Scott | ALRN | Common Stock | D | 19 276 | ||||||||
| 2017-06-28 | 3 | APPLE TREE PARTNERS II LP | ALRN | Common Stock | D | 502 | ||||||||
| 2017-06-28 | 3 | APPLE TREE PARTNERS II LP | ALRN | Common Stock | D | 502 | ||||||||
| 2017-06-28 | 3 | Yanchik Joseph A., III | ALRN | Common Stock | D | 247 592 | ||||||||
| 2017-06-28 | 3 | Yanchik Joseph A., III | ALRN | Common Stock | D | 247 592 | ||||||||
| 2017-06-28 | 3 | Platt Jon B. | ALRN | Common Stock | D | 200 | ||||||||
| 2017-06-28 | 3 | Platt Jon B. | ALRN | Common Stock | D | 200 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
